You searched for Antibody candidate - Page 52 of 69

News and Trends 1 Mar 2017

Swedish Oncology Biotech makes a Large IPO for its Peptides

…Squibb and is the first antibody therapy against multiple myeloma and was approved in May 2016. Moreover, Janssen’s anti-CD38 antibody daratumumab reached its primary endpoint in the first Phase III…

March 1, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 6 Jan 2023

Transgene approved for IV oncolytic virus trial

…powerful antitumor immune response, and a full length anti-CTLA4 antibody. By selectively targeting tumor cells and expressing IL-12 and the anti-CTLA4 antibody in the tumor microenvironment, TG6050 is expected to…

January 6, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 7 Sep 2022

Could COVID vaccine boosters become obsolete?

…the original strain) are actually very effective in neutralizing the Delta and Omicron variants. According to our findings, the effectiveness of the first antibody, TAU-1109, in neutralizing the Omicron strain…

September 7, 2022 - 5 minutesmins - By Jim Cornall

argenx efgartigimod treatment autoimmune disease myasthenia gravis

News and Trends 21 Dec 2021

Argenx’s Potential Blockbuster Gets FDA Nod for Autoimmune Disease

…marketed as Vyvgart, is an antibody fragment drug for use in adults with generalized myasthenia gravis. The FDA’s decision represents the first successful drug approval for argenx. According to Evaluate…

December 21, 2021 - 4 minutesmins - By Anita Chakraverty

More News! 17 Jul 2024

Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it

…candidate targeting tau proteins associated with Alzheimer’s disease. Asceneuron’s approach to tackling Alzheimer’s disease sets it apart in the competitive landscape of neurodegenerative disease treatments. While approved therapies for Alzheimer’s,…

July 17, 2024 - 10 minutesmins - By Jules Adam

News and Trends 13 Mar 2023

New therapy for prevention and treatment of COVID-19

…a novel, highly potent, anti-S2 camelid single-domain antibody, discovered at the VIB-UGent Center for Medical Biotechnology, which was developed as a candidate drug molecule by ExeVir Bio as XVR013. It…

March 13, 2023 - 4 minutesmins - By Jim Cornall

In Depth 13 Dec 2024

Is China the future of biotech?

…Chinese companies were biologics. The report notes that the number of antibody drug conjugate (ADC), bispecific antibody, and CAR-T pipelines has increased by seven, five, and four times, respectively. The…

December 13, 2024 - 12 minutesmins - By Jules Adam

virtiuakl biotech cloud lab robert thong industry emerald

News and Trends 23 May 2016

To Be – or Not To Be, a Virtual Biotech?

…one asset, with fixed costs well below 20% of their burn rate. For example, since its founding, the biotech XO1 (Hatfield, UK) operated virtually, working on a single anti-thrombin antibody…

May 23, 2016 - 5 minutesmins - By Dani Bancroft

News and Trends 6 Jun 2023

Shasqi using click chemistry to target cancer

…antibody drug conjugates,” said Mukul Agarwal, chief business officer at Shasqi. “The reliance on chemistry, not biology for drug activation, allows for the use of small molecules, peptides, and antibody…

June 6, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 7 Sep 2022

OncoResponse and Regeneron to evaluate drug combo for patients with advanced cancer

…in a separate biology cohort. About OR2805 OR2805 is a fully human antibody discovered using B cells derived from an elite responder to checkpoint inhibitor (CPI) therapy. This antibody binds…

September 7, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 24 Mar 2025

First-ever RIPTAC enters clinic: all you need to know about this new cancer approach

…antibody-drug conjugates (ADCs), which are composed of a monoclonal antibody, a cytotoxic drug – typically a chemotherapy – and a linker. But unlike ADCs, which deliver the drug specifically to…

March 24, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 12 Aug 2022

argenx secures European Commission approval for generalized myasthenia gravis treatment

…generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. The approval is applicable to all 27 European Union (EU) Member States plus Iceland, Norway and Liechtenstein. argenx said…

August 12, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Swedish Oncology Biotech makes a Large IPO for its Peptides

Transgene approved for IV oncolytic virus trial

Could COVID vaccine boosters become obsolete?

Argenx’s Potential Blockbuster Gets FDA Nod for Autoimmune Disease

Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it

New therapy for prevention and treatment of COVID-19

Is China the future of biotech?

To Be – or Not To Be, a Virtual Biotech?

Shasqi using click chemistry to target cancer

OncoResponse and Regeneron to evaluate drug combo for patients with advanced cancer

First-ever RIPTAC enters clinic: all you need to know about this new cancer approach

argenx secures European Commission approval for generalized myasthenia gravis treatment

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!